Mark Gerich
Clinical Director, University of Colorado Crohn's & Colitis Center · University of Colorado
Credentials: · · · · ·
History
PresentUniversity of Colorado Crohn's & Colitis Center
- Present
Until 2012- Until 2011
- Until 2007
University of California (Davis) Health System Program
Research
American Journal Of Pathology · 2018 · 452 citations
Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome
The Journal of Experimental Medicine · 2017 · 324 citations
Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition
Gastroenterology · 2008 · 321 citations
12 papers
11 papers
6 papers
5 papers
4 papers
4 papers
- JH
4 papers
4 papers
Clinical trials
- 2022–2023
Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
Principal investigator · Withdrawn · Early phase 1
University of Colorado, Denver
- 2022–2029
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Site PI · Recruiting
Mayo Clinic